The Pacemaker

AUTHORS

Andy-kach_thumbnail
Andy Kach
Principal
Bhargav_Mantha_thumbnail Brian_Chapman_thumbnail
Brian Chapman
Principal
Maria_thumbnail Matt-Scheitlin-London_thumbnail Tobi_Laczkowski_thumbnail Will_Randall_thumbnail

Latest Posts

Acing Medtech Pricing 2.0 With Analytics

Posted by Bhargav Mantha on May 28, 2019



3142_ContractingAnalytics_Blog (1)-1As we’ve heard many times, the traditional medtech operating model faces several headwinds:  buyer consolidation, a focus on value and outcomes, increased cost-to-serve and a change in buying preferences. All these trends have dealt a blow to medtech’s traditionally high margins and to a commercial model that was primarily sales-driven.

To counter these headwinds, medtech must leap forward to a pricing 2.0 model that ties pricing closely to clinical, economic and psychological value (rather than a cost-plus approach). Medtech must also create a value communication strategy, customer incentives that increase share-of-wallet and a more robust and customer-centric contracting and offering strategy. These strategies are essential. But are they sufficient to ensure that medtech can maximize its margins? We believe the answer is no.

Unless you have the right governance policies, execution discipline and analytics, you won’t be able to realize your profitability goals. We have seen many clients make strides towards the right pricing strategy but continue to see price erosion and revenue leakage. These clients are struggling with tension between the pricing team and the field, BU or regional teams (which leads to limited governance); a lack of data and analytics about customers and products (which leads to limited visibility into pricing and contracting performance); and limited investments made in vital analytics and platforms (which leads to inefficient pricing and contracting operations.)  

So, what can be done about it? I share my suggestions in my latest article for MD+DI. 


RELATED CONTENT 

BLOG POST: It Will Take Much More Than Technology Investments to Drive the Analytics Transformation in Medtech

BLOG POST: Three Barriers to Optimizing Your Pricing and Contracting Practices

BLOG POST: Gut Feeling, Instinct, Anecdotal Evidence: Why Can't We Just Use Data for Commercial Decisions?


 

Topics: Analytics, medtech, data analytics, pricing, advanced analytics

Click here to subscribe to The Pacemaker

Leave a comment

AUTHORS
Brian_Chapman_thumbnail
Brian Chapman
Principal,
ZS Associates
Tobi_Laczkowski_thumbnail
Tobi Laczkowski
Principal,
ZS Associates
Will_Randall_thumbnail
Will Randall
Manager,
ZS Associates
Matt-Scheitlin-London_thumbnail
Matt Scheitlin
Associate Principal,
ZS Associates
Andy-kach_thumbnail
Andy Kach
Associate Principal,
ZS Associates
Bhargav_Mantha_thumbnail
Bhargav Mantha
Associate Principal,
ZS Associates
SUBSCRIBE

Get 'THE PACEMAKER' Updates

Subscribe to receive email notifications whenever new blog posts are published.

×

Subscribe by Email

Search by Topic

see all